FRESH-PEF73376-en
National cohort on the vascular Ehlers-Danlos syndrome (SEDv)
RaDiCo-SEDVasc
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Paraclinical data (non-biological)','Paraclinical data (non-biological) : Imaging','Biological data','Economic data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Cardiology and vascular medicine | health theme |
| Paediatrics | health theme |
| Ehlers-Danlos syndrome | cim-11 |
| Socio-demographic and economic determinants | health determinant |
| Biological determinants: Genetic predisposition | health determinant |
| Behavioral determinants | health determinant |
| Healthcare system determinants: Use of care | health determinant |
| Healthcare system determinants: Access to care | health determinant |
| Socio-demographic and economic determinants: Employment | health determinant |
| Biological determinants | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}},{"value":"Adolescent (13 to 18 years)","concept":{"vocab":"MeSH","vocabURI":"D000293"}},{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Patients eligible for inclusion in this study have to fulfil all of the following criteria: - Patients (adults and children) with genetically-proven vEDS (presence of a pathogenic mutation at the COL3A1 gene); - Patients (or his/her legal guardian) who are signed informed consent or does not oppose to his/her personal data collection.","clusion_E":""}
| Name |
|---|
| Xavier;JEUNEMAITRE |
| Name | Role |
|---|---|
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | sponsor |
| Name |
|---|
| AGENCE NATIONALE DE LA RECHERCHE (ANR) |
| Name |
|---|
| European Reference Network |
| Agency name |
|---|
| CNIL |
| CESREES |
['']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2016-01-01 | 2026-01-01 |
| Standard |
|---|
| ['HPO, ICD10, Snomed CT, Orpha Codes and ORDO, Drug dictionary (DCIs)'] |
['Continuous data management; Data Management Plan and Data Validation Plan. Native controls and Query system']
Requests for access to RaDiCo-SEDVasc data (aggregated or individual) will be considered by the Scientific Committee following the submission of a summary of a specific research project, as defined in the Charter of access to resources.
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}